Skip to main content

Table 1 Baseline characteristics of participants (n = 60)

From: A correlational study of Weifuchun and its clinical effect on intestinal flora in precancerous lesions of gastric cancer

 

WFC (n = 30)

Control (n = 30)

Total (n = 60)

X2

t

P

Agea

50.37 (12.50)

53.90 (10.61)

52.13 (11.53)

 

1.2

0.243

Sex

      

 Male

16 (53.33)

15 (50.00)

31 (51.67)

0.268

 

0.796

 Female

14 (46.67)

15 (50.00)

29 (48.33)

 

Course of diseasea

5.57 (4.94)

5.87 (5.10)

5.72 (4.93)

 

0.2

0.818

Pathology

 Chronic Gastritisb

  Mild

7 (23.33)

10 (33.33)

17 (28.33)

1.888

 

0.596

  Moderate

20 (66.67)

19 (63.33)

39 (65.00)

 

  Severe

2 (6.67)

1 (3.33)

3 (5.00)

 

 Active Gastritisb

  Mild

11(36.67)

7 (23.33)

18 (30.00)

1.765

 

0.414

  Moderate

3 (10.00)

2 (6.67)

5 (8.33)

 

  Severe

0 (0.00)

0 (0.00)

0 (0.00)

 

 Atrophyb

  Mild

14 (46.67)

19 (63.33)

33 (55)

3.000

 

0.254

  Moderate

12 (40)

10 (33.33)

22 (36.67)

 

  Severe

4 (13.33)

1 (3.33)

5 (8.33)

 

 Intestinal metaplasiab

  Mild

16 (53.33)

21 (70.00)

37 (61.67)

2.739

 

0.493

  Moderate

10 (33.33)

7 (23.33)

17 (28.33)

 

  Severe

3 (10.00)

2 (6.67)

5 (8.33)

 

 Dysplasiab

  Mild

6 (20.00)

4 (13.33)

10 (16.67)

2.632

 

0.235

  Moderate

0 (0.00)

0 (0.00)

0 (0.00)

 

  Severe

0 (0.00)

0 (0.00)

0 (0.00)

 

 Aggregate scorec

5.70 (2.00)

4.97 (1.63)

  

1.6

0.125

Clinical Symptoms

 Aggregate scorec

15.32 (5.71)

 

15.92 (5.43)

 

3.5

0.929

  1. aYears, mean(SD)
  2. bThe number of cases meeting the diagnosis were counted and showed as cases (percent); absent cases were included when P value were calculated through two-sided X2 test
  3. cAggregate score represented sum of all grade score including absent, mild, moderate and severe; absent, 0; mild, 1; moderate, 2; severe, 3